GCMS analysis of products formed <i>in vivo</i> with <i>Sa</i>CYP76F39v1.

<p>GCMS analysis (extracted ion chromatograms) of compounds formed <i>in vivo</i> in yeast cells expressing <i>Sa</i>SSY, <i>Sa</i>CPR2 and (<b>A</b>) <i>Sa</i>CYP76F39v1 or (<b>B</b>) an empty vector. (<b>C</b>) Mass spectra of compounds corresponding to peaks 5–12 identified in (<b>A</b>). Peak numbers match the numbers in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0075053#pone-0075053-t001" target="_blank">Table 1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0075053#pone-0075053-g001" target="_blank">Figure 1</a>. Peaks in (<b>A</b>) and (<b>B</b>) marked with symbol (*) correspond to farnesol also produced in yeast cells without <i>Sa</i>CYP76F. Peaks in (<b>A</b>) marked with symbol (#) represent yeast <i>in vivo</i> modifications of santalols (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0075053#pone.0075053.s006" target="_blank">Figure S6</a>).